Cara Therapeutics Inc Banner Image

Cara Therapeutics Inc

  • Ticker CARA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Cara Therapeutics Inc Logo Image
  • 51-200 Employees
  • Based in Stamford, Connecticut
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. Its lead product candidate includes intravenous CR845, which has completed Phase 2 clinical trials for the treatment acute postoperative pain in adult patients, as well as in Phase 2 clinicalMore trials for the treatment of uremic pruritus disease.
Cara Therapeutics Inc

Most Recent Annual Report

Cara Therapeutics Inc
MOST RECENT 2021 Annual Report and Form 10K

Cara Therapeutics Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports